0001829126-23-006437.txt : 20231004 0001829126-23-006437.hdr.sgml : 20231004 20231004164050 ACCESSION NUMBER: 0001829126-23-006437 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230913 FILED AS OF DATE: 20231004 DATE AS OF CHANGE: 20231004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sire Group Ltd. CENTRAL INDEX KEY: 0001995392 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 231308546 BUSINESS ADDRESS: STREET 1: NO. 4, FRANKY BUILDING STREET 2: PROVIDENCE INDUSTRIAL ESTATE CITY: MAHE STATE: T2 ZIP: 00000 BUSINESS PHONE: 6012 484 4444 MAIL ADDRESS: STREET 1: NO. 4, FRANKY BUILDING STREET 2: PROVIDENCE INDUSTRIAL ESTATE CITY: MAHE STATE: T2 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shen Seow Gim CENTRAL INDEX KEY: 0001995393 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 231308545 MAIL ADDRESS: STREET 1: NO. 4, FRANKY BUILDING STREET 2: PROVIDENCE INDUSTRIAL ESTATE CITY: MAHE STATE: T2 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 3 1 ownership.xml FORM 3 X0206 3 2023-09-13 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001995392 Sire Group Ltd. NO. 4, FRANKY BUILDING, PROVIDENCE INDUSTRIAL ESTATE MAHE T2 00000 SEYCHELLES 0 0 1 0 0001995393 Shen Seow Gim NO. 4, FRANKY BUILDING, PROVIDENCE INDUSTRIAL ESTATE MAHE T2 00000 SEYCHELLES 0 0 1 0 Common Stock 20836266 D Series AA Convertible Preferred Stock ("Preferred Stock") 0.466 2023-09-13 Common Stock 20836266 D The total number of shares into which the Preferred Stock ultimately is convertible is as set forth in the table, but the Preferred Stock contains restrictions limiting the number of converted shares that the reporting persons may have at any one time, without Issuer stockholder approval, to 3,001,757 shares. Seow Gim Shen owns the shares beneficial ownership is indirect, by virtue of his sole ownership of The Sire Group Ltd., which owns the shares directly. Not Applicable THE SIRE GROUP LTD, By: /s/ Seow Gim Shen, Chief Executive Officer 2023-10-04 /s/ Seow Gim Shen 2023-10-04